| Literature DB >> 32613131 |
Jimena S Cadona1, Julia Burgán1, Juliana González1, Ana V Bustamante1, A Mariel Sanso1.
Abstract
Shiga toxin-producing Escherichia coli (STEC) is a zoonotic foodborne pathogen associated with hemolytic uremic syndrome (HUS) that vary in their ability to cause disease in humans. STEC represents a serious problem for public health and Argentina is the country with the highest HUS incidence worldwide. Non-LEE effector (nle) genes, present on pathogenicity islands (PAIs), encode translocated substrates of the type III secretion system (T3SS), which could have an important role in STEC virulence. Particularly, nleB is one of the main effector genes proposed as a virulence marker that is involved in the action of T3SS during the STEC infection. NleB inhibits the inflammatory response of the host cell allowing the bacteria to persist in the first stage of the infection. In order to identify the potential risk of STEC strains for public health, the aim of this study was to evaluate and compare basal nleB transcription of 24 STEC strains belonging to 10 serotypes isolated from cattle, food and patients. The results showed differences in nleB transcription among strains. Some non-O157:H7 strains presented transcription levels above the control, an O157:H7 HUS-producing strain. On the other hand, no significant differences were found in basal transcription levels associated with origin or serotype but differences were found between HUS and non-HUS strains. These differences in nleB transcription may be of importance in STEC pathogenesis and could help to differentiate high and low virulence STEC strains.Entities:
Keywords: Bacteria; Gene expression; Genetics; Hemolytic uremic syndrome (HUS); Microbiology; Non-LEE effector; Shiga toxin-producing Escherichia coli (STEC); Virulence; nleB transcription
Year: 2020 PMID: 32613131 PMCID: PMC7322132 DOI: 10.1016/j.heliyon.2020.e04277
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Strain features and fold change results.
| Strain | Serotype | Origin (and clinical manifestation in human | Isolation period | Virulence profile | Fold change | Cluster number |
|---|---|---|---|---|---|---|
| 224.2.2 | human (HC) | 2002–2009 | ||||
| 323.5.1 | human (HUS) | 2002–2009 | ||||
| 73.2.2 | human (D) | 2002–2009 | ||||
| 306.10.3 | human (D) | 2002–2009 | ||||
| 299 | human (HC) | 2002–2009 | - | |||
| 430 | human (AC) | 2002–2009 | - | |||
| 355 | human (D) | 2002–2009 | - | |||
| 74.2 | human (HUS) | 2002–2009 | ||||
| FB 78 | cattle | 2000 | ||||
| FB 79 | cattle | 2000 | ||||
| FB 91 | cattle | 2000 | ||||
| 3.1.2 | human (HC) | 2002–2009 | ||||
| 506.1.5.2 | human (HC) | 2002–2009 | ||||
| FB 67e | cattle | 2000 | ||||
| FB 87 | cattle | 2000 | ||||
| FB 92 | cattle | 2000 | ||||
| FB 81e | cattle | 2000 | ||||
| FB 12 | cattle | 2000 | ||||
| 34 | human (HUS) | 2003 | R | |||
| GAL 26 | human (HUS) | 1996–1997 | ||||
| HT 2-15 | food | 2000 | - | |||
| T 83-1 | cattle | 1995–1996 | ||||
| FO 127-3 | cattle | 2001 | ||||
| FB 15 | cattle | 2000 |
Control strain: R.
Human strain: HUS, strain isolated from a patient with hemolytic uremic syndrome; HC, strain isolated from a patient with hemorrhagic colitis; D, strain isolated from a patient with diarrhea; AC, strain isolated from an asymptomatic carrier.
Presence of genes encoding for Shiga toxin 1 and 2 (vtx and vtx), intimin (eae) and enterohemolysin (ehxA).
Fold change values obtained by the ΔΔCT method (Pfaffl, 2001). NE: no detectable transcription.
Clusters based on K-means algorithm according to fold change values of each isolate. K-means analysis was performed for three clusters (k = 3). Isolates "299", "355" and "HT 2–15" were not included in ANOVA.
Figure 1Relative basal nleB transcription of STEC strains. Strain "34" (serotype O157:H7) was used as control strain. Those strains with fold change values > 1 have higher transcription levels than control and, those with fold change values < 1, lower transcription levels. Strain of O128:NM serotype ("430") was not included in the figure because no transcription was detected under the experimental conditions tested.
Figure 2(a–c) Comparison of basal transcription levels of nleB according to: origin (a); serotype (b); and K-means clustering based on fold change values (c). The figures show the means for each group and y-axes show basal nleB expression relative to the control strain expression, an O157:H7 isolated from a clinical sample (HUS), expressed as fold change values. Error bars indicate standard error. Different letters indicate significant differences between groups (p-value ≤ 0.05) and means with the same letter are not statistically different.
Figure 3(a,b) Comparison of basal transcription levels of nleB according to the origin of the strains: HUS and non-HUS human isolates (a); HUS, non-HUS and cattle isolates (b). The figures show the means for each group and y-axes show basal nleB transcription relative to the control strain transcription, an O157:H7 isolated from a clinical sample (HUS), expressed as fold change values. Error bars indicate standard error. Different letters indicate significant differences between groups (p-value ≤ 0.05) and means with the same letter are not statistically different.